{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:47:04Z","timestamp":1790628424522,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-497","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:06:34Z","timestamp":1434611194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Matheus","family":"Bertanha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcone Lima","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Pinheiro L\u00facio Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil Victor","family":"de Oliveira Mari\u00faba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Elias","family":"Farres Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Gibin","family":"Jaldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamilton Almeida","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston Bonetti","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,19]]},"reference":[{"issue":"4","key":"2369_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0741-5214(95)70195-8","volume":"21","author":"JM Porter","year":"1995","unstructured":"Porter JM, Moneta GL: Reporting standards in venous disease - an update. J Vasc Surg. 1995, 21 (4): 635-645. 10.1016\/S0741-5214(95)70195-8.","journal-title":"J Vasc Surg"},{"issue":"8","key":"2369_CR2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1524-4725.2012.02422.x","volume":"38","author":"JD Peterson","year":"2012","unstructured":"Peterson JD, Goldman MP, Weiss RA, Duffy DM, Fabi SG, Weiss MA, Guiha I: Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 2012, 38 (8): 1322-1330. 10.1111\/j.1524-4725.2012.02422.x.","journal-title":"Dermatol Surg"},{"issue":"5","key":"2369_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1524-4725.1999.08263.x","volume":"25","author":"S McCoy","year":"1999","unstructured":"McCoy S, Evans A, Spurrier N: Sclerotherapy for leg telangiectasia \u2013 a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 1999, 25 (5): 381-386. 10.1046\/j.1524-4725.1999.08263.x.","journal-title":"Dermatol Surg"},{"issue":"3","key":"2369_CR4","first-page":"261","volume":"32","author":"JP Benigni","year":"2013","unstructured":"Benigni JP, Bihari I, Rabe E, Uhl JF, Partsch H, Cornu-Thenard A, Jawien A, UIP - Union Internationale de Phl\u00e9bologie: Venous symptoms in C0 and C1 patients: UIP consensus document. Int Angiol. 2013, 32 (3): 261-265.","journal-title":"Int Angiol"},{"key":"2369_CR5","doi-asserted-by":"crossref","unstructured":"Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol. 1996, 34 (3): 523-528. 10.1016\/S0190-9622(96)90467-3.","DOI":"10.1016\/S0190-9622(96)90467-3"},{"issue":"6","key":"2369_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archsurg.1974.01360060063016","volume":"109","author":"JT Hobbs","year":"1974","unstructured":"Hobbs JT: Surgery and sclerotherapy in the treatment of varicose veins: a random trial. Arch Surg. 1974, 109 (6): 793-10.1001\/archsurg.1974.01360060063016.","journal-title":"Arch Surg"},{"key":"2369_CR7","first-page":"CD008826","volume":"12","author":"L Schwartz","year":"2011","unstructured":"Schwartz L, Maxwell H: Sclerotherapy for lower limb telangiectasias. Cochrane Database Syst Rev. 2011, 12: CD008826-","journal-title":"Cochrane Database Syst Rev"},{"key":"2369_CR8","first-page":"CD001732","volume":"4","author":"PV Tisi","year":"2006","unstructured":"Tisi PV, Beverley C, Rees A: Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev. 2006, 4: CD001732-","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2369_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1524-4725.2000.00033.x","volume":"26","author":"JJ Bergan","year":"2000","unstructured":"Bergan JJ, Weiss RA, Goldman MP: Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg. 2000, 26 (6): 535-542. 10.1046\/j.1524-4725.2000.00033.x.","journal-title":"Dermatol Surg"},{"issue":"3","key":"2369_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1258\/phleb.2012.012051","volume":"28","author":"T Willenberg","year":"2013","unstructured":"Willenberg T, Smith PC, Shepherd A, Davies AH: Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology. 2013, 28 (3): 123-131. 10.1258\/phleb.2012.012051.","journal-title":"Phlebology"},{"issue":"4","key":"2369_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1524-4725.1995.tb00184.x","volume":"21","author":"P Conrad","year":"1995","unstructured":"Conrad P, Malouf GM, Stacey MC: The Australian Polidocanol (Aethoxysklerol) Study - Results at 2 Years. Dermatol Surg. 1995, 21 (4): 334-336. 10.1111\/j.1524-4725.1995.tb00184.x.","journal-title":"Dermatol Surg"},{"issue":"5","key":"2369_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1524-4725.1994.tb01630.x","volume":"20","author":"NS Sadick","year":"1994","unstructured":"Sadick NS: Hyperosmolar versus detergent sclerosing agents in sclerotherapy. J Dermatol Surg Oncol. 1994, 20 (5): 313-316. 10.1111\/j.1524-4725.1994.tb01630.x.","journal-title":"J Dermatol Surg Oncol"},{"issue":"4","key":"2369_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1258\/phleb.2011.010094","volume":"27","author":"J Zhang","year":"2012","unstructured":"Zhang J, Jing Z, Schliephake DE, Otto J, Malouf GM, Gu YQ: Efficacy and safety of Aethoxysklerol\u00ae(polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study). Phlebology. 2012, 27 (4): 184-190. 10.1258\/phleb.2011.010094.","journal-title":"Phlebology"},{"issue":"12","key":"2369_CR14","first-page":"1444","volume":"32","author":"S Kobayashi","year":"2006","unstructured":"Kobayashi S, Crooks S, Eckmann DM: Dose and time dependent liquid sclerosant effects on endothelial cell death. Dermatol Surg. 2006, 32 (12): 1444-1452.","journal-title":"Dermatol Surg"},{"issue":"s2","key":"2369_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1524-4725.2009.01469.x","volume":"36","author":"DM Duffy","year":"2010","unstructured":"Duffy DM: Sclerosants: a comparative review. Dermatol Surg. 2010, 36 (s2): 1010-1025.","journal-title":"Dermatol Surg"},{"issue":"14","key":"2369_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMc0707265","volume":"358","author":"RP Ceulen","year":"2008","unstructured":"Ceulen RP, Sommer A, Vernooy K: Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008, 358 (14): 1525-1526. 10.1056\/NEJMc0707265.","journal-title":"N Engl J Med"},{"issue":"2","key":"2369_CR17","first-page":"153","volume":"28","author":"MM Marrocco\u2012Trischitta","year":"2002","unstructured":"Marrocco\u2012Trischitta MM, Guerrini P, Abeni D, Stillo F: Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg. 2002, 28 (2): 153-155.","journal-title":"Dermatol Surg"},{"issue":"6","key":"2369_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jvs.2004.09.027","volume":"40","author":"B Eklof","year":"2004","unstructured":"Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW, American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification: Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004, 40 (6): 1248-1252. 10.1016\/j.jvs.2004.09.027.","journal-title":"J Vasc Surg"},{"issue":"5","key":"2369_CR19","first-page":"600","volume":"34","author":"H Partsch","year":"2008","unstructured":"Partsch H, Clark M, Mosti G, Steinlechner E, Schuren J, Abel M, Benigni JP, Coleridge-Smith P, Cornu-Th\u00e9nard A, Flour M, Hutchinson J, Gamble J, Issberner K, Juenger M, Moffatt C, Neumann HA, Rabe E, Uhl JF, Zimmet S: Classification of compression bandages: practical aspects. Dermatol Surg. 2008, 34 (5): 600-609.","journal-title":"Dermatol Surg"},{"issue":"3","key":"2369_CR20","first-page":"367","volume":"30","author":"P Kern","year":"2004","unstructured":"Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D: Single blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004, 30 (3): 367-372.","journal-title":"Dermatol Surg"},{"issue":"5","key":"2369_CR21","first-page":"687","volume":"30","author":"E Rabe","year":"2004","unstructured":"Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M, German Society of Phlebology: Guidelines for sclerotherapy of varicose veins (ICD 10: I83. 0, I83. 1, I83. 2, and I83. 9). Dermatol Surg. 2004, 30 (5): 687-693.","journal-title":"Dermatol Surg"},{"issue":"6","key":"2369_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/0268355513483280","volume":"29","author":"E Rabe","year":"2013","unstructured":"Rabe E, Breu F, Cavezzi A, Smith PC, Frullini A, Gillet J, Guex J, Hamel-Desnos C, Kern P, Partsch B, Ramelet A, Tessari L, Pannier F, for the Guideline Group: European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2013, 29 (6): 338-354.","journal-title":"Phlebology"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-15-497\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:45:24Z","timestamp":1548110724000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-497","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"5 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"497"}}